MedPath

Donor Breast Milk and Breastfeeding Rates

Not Applicable
Completed
Conditions
Breastfeeding, Exclusive
Breastfeeding
Interventions
Other: Donor Breast Milk
Registration Number
NCT04572581
Lead Sponsor
University of California, Los Angeles
Brief Summary

The purpose of this pilot study is to determine if a randomized controlled study comparing a human milk diet versus a formula supplemented diet in late preterm and term infants in the neonatal intensive care unit (NICU) is feasible.

Detailed Description

In late preterm infants and term neonates in the NICU whose mothers intend to breastfeed, this pilot study seeks to 1. determine study feasibility (consent rate, study completion rate, and rate of adherence to study diet), and 2. determine whether a dietary supplementation with donor human milk vs. formula improves: a. the percentage of maternal milk consumption at time of discharge from the NICU, or 7 days of age, whichever is later, b. breastfeeding rates and intent to breastfeed at 6-8 weeks chronological age, and c. breast feeding duration.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Gestational age >34 weeks and 0 days
  • Mother's intent to breast feed
  • NICU admission which is predicted to be at least 72 hours from time of admission
Read More
Exclusion Criteria
  • Confirmed genetic disorders and syndromes or other disorders known to affect growth and ability to bottle feed or breast feed (i.e., Trisomies)
  • Common neonatal congenital anomalies (cardiac disease, congenital gastrointestinal disorders, etc)
  • Commonly accepted contraindications for breast feeding (HIV, galactosemia, herpes lesions on the breast, maternal use of drugs that are considered contraindicated with breast feeding including marijuana)
  • Infant admitted to the intensive care unit who is receiving invasive respiratory support (intubation) and/or ionotropic medications
  • Any infant whose care is considered futile by the primary medical team
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Exclusively Human Milk DietDonor Breast MilkThis group will receive human milk only. If the mother is not producing enough breast milk, this group will receive donor milk supplementation.
Primary Outcome Measures
NameTimeMethod
Study Feasibility_26-8 weeks chronological age

Feasibility will be evaluated by: study completion rate

Study Feasibility_36-8 weeks chronological age

Feasibility will be evaluated by: rate of adherence to the study diet.

Study Feasibility_16-8 weeks chronological age

Feasibility will be evaluated by: consent rate

Secondary Outcome Measures
NameTimeMethod
Growth: Height6-8 weeks chronological age

height in centimeters reported as a z-score

Percentage of Human Milk Consumption at Dischargeat the time of NICU discharge or 7 days of age, whichever is later

Maternal milk/total milk (percent) consumed by the neonate over 48 hours

Percentage of Human Milk Consumption After Discharge6-8 weeks chronological age

Maternal milk/total milk (percent) consumed by the infant over 48 hours

Growth: Head Circumference6-8 weeks chronological age

head circumference in centimeters reported as a z-score

Intent to Breastfeed6-8 weeks chronological age

Mother's desire to continue to breastfeed: specifically assessed by asking the mother if she plans to exclusively breastfeed or not. Answers will be recorded as yes or no.

Breastfeeding duration6-8 weeks chronological age

time infant received breastmilk since birth

Growth: Weight6-8 weeks chronological age

Weight in kilograms reported as a z-score

Trial Locations

Locations (2)

Ronald Reagan UCLA Medical Center

🇺🇸

Los Angeles, California, United States

Santa Monica-UCLA

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath